IP Library Granted Patent US 9,890,170
Granted Patent B2
US 9,890,170 · App. 15/336,193 · Granted Feb 13, 2018

Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse, depression, anxiety, or a compulsive disorder

Inventors: John Lewis (Winscombe, GB); Stephen Husbands (Bath, GB)
Assignee: The University of Bath
C07D489/12A61K31/4748A61K31/485C07D489/10C07D491/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,890,170
App. No.
15/336,193
Granted
Feb 13, 2018
Kind
B2
Abstract

The invention provides a method of treating drug and alcohol abuse, depression, anxiety, or a compulsive disorder in a subject comprising administering to the subject a compound having formula 2: or a pharmaceutically acceptable salt or solvate thereof, wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , and X are as defined in the specification.

Claims (26)

1. A compound of formula 2, or a pharmaceutically acceptable salt or solvate thereof,

wherein:

R is H or alkyl

R 1 is alkyl or alkenyl;

R 2 is H;

R 4 and R 5 are methyl;

R 3 is aryl or heteroaryl, either of which may be substituted or unsubstituted, and X is —CH 2 CH 2 — or —CH═CH—.

2. The compound of claim 1 , wherein R is H.

3. The compound of claim 1 , wherein R 3 is unsubstituted or substituted phenyl, or unsubstituted or substituted pyridyl.

4. The compound of claim 3 , wherein R 3 is phenyl, optionally substituted with a halogen, methyl, hydroxyl or methoxy.

5. The compound of claim 3 , wherein R 3 is pyridyl, optionally substituted with a halogen, methyl, hydroxyl or methoxy.

6. The compound of claim 1 , wherein R 1 is n-propyl.

7. The compound of claim 1 , wherein R 1 is —CH 2 CH═CH 2 .

8. A composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable excipient or carrier.

9. A method of treating opiate abuse, alcohol abuse, cocaine abuse, depression, anxiety, or a compulsive disorder, the method comprising administering an effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.

10. The method of claim 9 for treating opiate abuse, alcohol abuse, or cocaine abuse.

11. The method of claim 10 , wherein said treating prevents relapse of the opiate abuse, alcohol abuse, or cocaine abuse.

12. The method of claim 9 for treating depression.

13. The method of claim 9 for treating anxiety.

14. The method of claim 9 for treating a compulsive disorder.

15. A method of treating opiate abuse, alcohol abuse, cocaine abuse, depression, anxiety, or a compulsive disorder, the method comprising administering an effective amount of the composition of claim 8 , or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.

16. The method of claim 15 for treating opiate abuse, alcohol abuse, or cocaine abuse.

17. The method of claim 16 , wherein said treating prevents relapse of the opiate abuse, alcohol abuse, or cocaine abuse.

18. The method of claim 15 for treating depression.

19. The method of claim 15 for treating anxiety.

20. The method of claim 15 for treating a compulsive disorder.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2017
From: LEWIS, JOHN
To: THE UNIVERSITY OF BATH
Reel/Frame 043645/0959 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2017
From: HUSBANDS, STEPHEN
To: THE UNIVERSITY OF BATH
Reel/Frame 043645/0977 →
Priority Claims (1)
GB 1111775.1 · Jul 8, 2011 · national
Continuity (4)
Continuation 15001553 · Jan 20, 2016
Continuation 14674578 · Mar 31, 2015
Continuation 14131361
Related Publication 20170044173A1 · Feb 16, 2017